Drug Discovery Product Showcase

  1. Complex Synthetic Molecule Development, Manufacturing 11/12/2024

    See how our innovative capabilities and advanced technologies can optimize the development and manufacturing of complex synthetics for drug substances, medical devices, and diagnostic agents.

  2. Your Molecule. Our Mission. 11/12/2024

    Our scientists excel at building connections. Start a conversation today and discover the benefits of partnering with a collaborative CDMO.

  3. Antibody Production: Scale-Up Menu 10/23/2024

    Whether you are ramping up for clinical trials or preparing for large-scale GMP production, explore a variety of options tailored for a complete mAb process, available at both pilot and production scales.

  4. A Proven Combination For AAV Production 10/16/2024

    Learn about a combination of high-performing raw materials, advanced synthetic transfection reagents, and chemically defined HEK media that can overcome the challenges of commercial-scale production.

  5. Which Organ-Chip Design Is Right For You? 10/15/2024

    Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.

  6. Chip-R1™ Rigid Chip 10/8/2024

    Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.

  7. NanoImprove Your Small And Large Molecule Formulations 9/24/2024

    Can your product be NanoImproved? Find out at at-a-glance with a 4-page informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.

  8. Modular Environments For Biomanufacturing Capacity 9/16/2024

    Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

  9. Process Trains For Flexible, Configurable Biopharma Manufacturing Capacity 9/16/2024

    Transform your space to fit your needs

    Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan your agile manufacturing strategy with greater efficiency and integration to address current and future capacity needs.

  10. Nitrosamine Capabilities 8/22/2024

    Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology to boost your drug product development.